Last reviewed · How we verify

Desobesi (FENPROPOREX)

FDA-approved withdrawn Small molecule Quality 24/100

At a glance

Generic nameFENPROPOREX
Drug classfenproporex
ModalitySmall molecule
Therapeutic areaMetabolic
PhaseFDA-approved
Annual revenue172

Approved indications

Common side effects

No common side effects on file.

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
SEC EDGARRevenue + earnings

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: